p strong Prestige Consumer Healthcare Inc Q1 2025 Earnings Summary strongpp strong Company Overvie
Intellectia.AI Updated: 1970-01-01
Prestige Consumer Healthcare Inc. Q1 2025 Earnings Summary
Company Overview:
Prestige Consumer Healthcare Inc. reported its financial results for the first quarter of fiscal year 2025, ending June 30, 2024.
Key Financial Metrics:
| Metric | Q1 2025 | Q1 2024 | YoY Change | Wall Street Consensus | Comparison |
|---|---|---|---|---|---|
| Total Revenue | $267.1 million | $279.3 million | -4.4% | $260.41 million | Above |
| Earnings Per Share | $0.81 | $1.08 | -25.0% | $0.86 | Below |
Interpretation: Despite a year-over-year decline in total revenue and earnings per share (EPS), Prestige Consumer Healthcare Inc. managed to exceed Wall Street consensus estimates for revenue but fell short on EPS. The decline in revenue and earnings can be attributed to supply chain challenges and increased costs.
Revenue Breakdown by Major Segments:
| Segment | Q1 2025 Revenue | Q1 2024 Revenue | YoY Change | Comments |
|---|---|---|---|---|
| North American OTC Healthcare | $227.2 million | $240.0 million | -5.6% | Decrease primarily in Cough & Cold and Women's Health categories, partly offset by Eye & Ear Care. |
| International OTC Healthcare | $39.9 million | $38.2 million | +5.0% | Increase mainly in Gastrointestinal and Eye & Ear Care categories, offset by Women's Health. |
Interpretation: The North American OTC Healthcare segment experienced a notable decline primarily due to reduced sales in specific categories, whereas the International segment showed positive growth driven by increased sales in Gastrointestinal and Eye & Ear Care products.
Dividends or Share Repurchase Program:
- Authorized Share Repurchase: Up to $300.0 million (announced on May 6, 2024)
- Share Repurchases during Q1 2025: 401,111 shares under the repurchase program.
Stock Price Movement: After the event, the stock price of Prestige Consumer Healthcare Inc. fell by approximately 0.35%.
Conclusion: Prestige Consumer Healthcare Inc. faced challenges in the first quarter of fiscal year 2025 with a decline in revenue and earnings per share due to increased supply chain costs and changing consumer patterns. Despite these hurdles, the company was able to surpass the consensus revenue estimate. The authorization of a significant share repurchase program indicates confidence in the company’s long-term prospects.
